These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 38972785)

  • 1. Neoadjuvant Versus Adjuvant Chemotherapy in Non-Metastatic Locally-Advanced Stage Radical Cystectomy Candidates.
    de Angelis M; Siech C; Jannello LMI; Bello FD; Peñaranda NR; Goyal JA; Touma N; Tian Z; Longo N; de Cobelli O; Chun FKH; Micali S; Saad F; Shariat SF; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2024 Oct; 22(5):102132. PubMed ID: 38972785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoadjuvant chemotherapy before radical cystectomy in patients with organ-confined and non-organ-confined urothelial carcinoma.
    de Angelis M; Jannello LMI; Siech C; Baudo A; Di Bello F; Goyal JA; Tian Z; Longo N; de Cobelli O; Chun FKH; Saad F; Shariat SF; Carmignani L; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI
    Urol Oncol; 2025 Jan; 43(1):62.e1-62.e6. PubMed ID: 39424431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Race/Ethnicity Affects Access and Survival Differences After Neoadjuvant or Adjuvant Chemotherapy at Radical Cystectomy in Urothelial Carcinoma Patients.
    de Angelis M; Jannello LMI; Siech C; Di Bello F; Peñaranda NR; Goyal JA; Tian Z; Longo N; de Cobelli O; Chun FKH; Puliatti S; Saad F; Shariat SF; Gandaglia G; Moschini M; Montorsi F; Briganti A; Karakiewicz PI
    J Racial Ethn Health Disparities; 2024 Aug; ():. PubMed ID: 39160435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant Chemotherapy vs Observation for Patients With Adverse Pathologic Features at Radical Cystectomy Previously Treated With Neoadjuvant Chemotherapy.
    Seisen T; Jamzadeh A; Leow JJ; Rouprêt M; Cole AP; Lipsitz SR; Kibel AS; Nguyen PL; Sun M; Menon M; Bellmunt J; Choueiri TK; Trinh QD
    JAMA Oncol; 2018 Feb; 4(2):225-229. PubMed ID: 28837718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of adjuvant chemotherapy in locally advanced urothelial carcinoma of the bladder treated with cystectomy.
    Del Pozo Jiménez G; Herranz Amo F; Arranz Arija JA; Rodríguez Fernández E; Subirá Ríos D; Lledó García E; Bueno Chomón G; Cancho Gil MJ; Carballido Rodríguez J; Hernández Fernández C
    Actas Urol Esp (Engl Ed); 2020 Mar; 44(2):94-102. PubMed ID: 31866159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
    Rosiello G; Knipper S; Palumbo C; Pecoraro A; Luzzago S; Deuker M; Tian Z; Gandaglia G; Gallina A; Montorsi F; Shariat SF; Saad F; Briganti A; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
    Mazzone E; Nazzani S; Knipper S; Tian Z; Preisser F; Gallina A; Soulières D; Tilki D; Montorsi F; Shariat SF; Saad F; Briganti A; Wisnivesky J; Karakiewicz PI
    Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of pathological response following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer: the PRE-PREVENCYS trial.
    Hinsenveld FJ; Noordman BJ; Boormans JL; Voortman J; van Leenders GJLH; van der Pas SL; van Beek SC; Oprea-Lager DE; Vis AN
    BMC Cancer; 2021 Oct; 21(1):1161. PubMed ID: 34715822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
    Mistretta FA; Cyr SJ; Luzzago S; Mazzone E; Knipper S; Palumbo C; Tian Z; Nazzani S; Saad F; Montanari E; Tilki D; Briganti A; Shariat SF; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radical Cystectomy vs. Multimodality Treatment in T2N0M0 Bladder Cancer: A Population-based, Age-matched Analysis.
    Deuker M; Krimphove MJ; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Shariat SF; Black PC; Kassouf W; Tilki D; Saad F; Chun FKH; Karakiewicz PI
    Clin Genitourin Cancer; 2021 Aug; 19(4):e264-e271. PubMed ID: 33972185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncologic Outcomes for Patients with Residual Cancer at Cystectomy Following Neoadjuvant Chemotherapy: A Pathologic Stage-matched Analysis.
    Bhindi B; Frank I; Mason RJ; Tarrell RF; Thapa P; Cheville JC; Costello BA; Pagliaro LC; Karnes RJ; Thompson RH; Tollefson MK; Boorjian SA
    Eur Urol; 2017 Nov; 72(5):660-664. PubMed ID: 28545841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes.
    Boeri L; Soligo M; Frank I; Boorjian SA; Thompson RH; Tollefson M; Quevedo FJ; Cheville JC; Karnes RJ
    Eur Urol Oncol; 2019 Jul; 2(4):390-396. PubMed ID: 31277775
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radical Cystectomy vs. Radiotherapy in Urothelial Bladder Cancer in Elderly and Very Elderly Patients.
    Horlemann B; Würnschimmel C; Hoeh B; Sorce G; Chierigo F; Flammia RS; Tian Z; Saad F; Briganti A; Shariat SF; Galucci M; Chun FKH; Graefen M; Karakiewicz PI
    Clin Genitourin Cancer; 2022 Feb; 20(1):93.e1-93.e9. PubMed ID: 34620567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Survival After Partial Cystectomy for Variant Histology Bladder Cancer Compared With Urothelial Carcinoma: A Population-based Study.
    Luzzago S; Palumbo C; Rosiello G; Knipper S; Pecoraro A; Deuker M; Mistretta FA; Tian Z; Musi G; Montanari E; Shariat SF; Saad F; Briganti A; de Cobelli O; Karakiewicz PI
    Clin Genitourin Cancer; 2020 Apr; 18(2):117-128.e5. PubMed ID: 32035800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of adjuvant chemotherapy in radical cystectomy patients aged >65 years: a population-based study from the surveillance epidemiology and end results (SEER)-medicare database.
    Schiffmann J; Sun M; Gandaglia G; Tian Z; Popa I; Larcher A; Briganti A; McCORMACK M; Shariat SF; Montorsi F; Graefen M; Saad F; Karakiewicz PI
    Minerva Urol Nefrol; 2017 Apr; 69(2):173-180. PubMed ID: 27733752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Micropapillary Versus Urothelial Carcinoma of the Urinary Bladder: Stage at Presentation and Efficacy of Chemotherapy Across All Stages-A SEER-based Study.
    Deuker M; Stolzenbach LF; Collà Ruvolo C; Nocera L; Mansour M; Tian Z; Roos FC; Becker A; Kluth LA; Tilki D; Shariat SF; Saad F; Chun FKH; Karakiewicz PI
    Eur Urol Focus; 2021 Nov; 7(6):1332-1338. PubMed ID: 32962961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer in the Current Real World Setting in the USA.
    Hanna N; Trinh QD; Seisen T; Vetterlein MW; Sammon J; Preston MA; Lipsitz SR; Bellmunt J; Menon M; Choueiri TK; Abdollah F
    Eur Urol Oncol; 2018 May; 1(1):83-90. PubMed ID: 31100232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic and survival outcomes following radical cystectomy for "progressive" and "de novo" muscle-invasive bladder cancer: A meta-analysis stratified by neoadjuvant chemotherapy status.
    Xia L; Dadabhoy A; Wood EL; Mehta SV; Roberson DS; Guzzo TJ; Bivalacqua TJ; Daneshmand S
    Urol Oncol; 2024 Oct; 42(10):333.e1-333.e13. PubMed ID: 38697874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of Patient Selection for Neoadjuvant Chemotherapy in Muscle-invasive Urothelial Carcinoma of the Bladder.
    Hensley PJ; Goodwin J; Davenport DL; Strup SE; James A
    Clin Genitourin Cancer; 2018 Aug; 16(4):e851-e858. PubMed ID: 29548614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.